These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17567631)

  • 1. Propensity to release endotoxin after two repeated doses of cefuroxime in an in vitro kinetic model: higher release after the second dose.
    Goscinski G; Tano E; Löwdin E; Sjölin J
    J Antimicrob Chemother; 2007 Aug; 60(2):328-33. PubMed ID: 17567631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxin release from Escherichia coli after exposure to tobramycin: dose-dependency and reduction in cefuroxime-induced endotoxin release.
    Sjölin J; Goscinski G; Lundholm M; Bring J; Odenholt I
    Clin Microbiol Infect; 2000 Feb; 6(2):74-81. PubMed ID: 11168076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in the propensity to release endotoxin after cefuroxime exposure in different gram-negative bacteria: uniform and dose-dependent reduction by the addition of tobramycin.
    Goscinski G; Lundholm M; Odenholt I; Sjölin J
    Scand J Infect Dis; 2003; 35(1):40-6. PubMed ID: 12685883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic-induced release of endotoxin from bacteria in vitro.
    Crosby HA; Bion JF; Penn CW; Elliott TS
    J Med Microbiol; 1994 Jan; 40(1):23-30. PubMed ID: 8289210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a single dose of tobramycin on systemic inflammatory response-induced acute kidney injury in a 6-hour porcine model.
    Lipcsey M; Carlsson M; Larsson A; Algotsson L; Eriksson M; Lukinius A; Sjölin J
    Crit Care Med; 2009 Oct; 37(10):2782-90. PubMed ID: 19707126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study.
    Dofferhoff AS; Nijland JH; de Vries-Hospers HG; Mulder PO; Weits J; Bom VJ
    Scand J Infect Dis; 1991; 23(6):745-54. PubMed ID: 1815338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes.
    Dofferhoff AS; Esselink MT; de Vries-Hospers HG; van Zanten A; Bom VJ; Weits J; Vellenga E
    J Antimicrob Chemother; 1993 Mar; 31(3):373-84. PubMed ID: 8486571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extension of Pharmacokinetic/Pharmacodynamic Time-Kill Studies To Include Lipopolysaccharide/Endotoxin Release from Escherichia coli Exposed to Cefuroxime.
    Thorsted A; Tano E; Kaivonen K; Sjölin J; Friberg LE; Nielsen EI
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of SpeA from Streptococcus pyogenes after exposure to penicillin: dependency on dose and inhibition by clindamycin.
    Goscinski G; Tano E; Thulin P; Norrby-Teglund A; Sjölin J
    Scand J Infect Dis; 2006; 38(11-12):983-7. PubMed ID: 17148065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach.
    González N; Aguilar L; Alou L; Giménez MJ; Sevillano D; Torrico M; Cafini F; Coronel P; Prieto J
    J Antimicrob Chemother; 2009 Jun; 63(6):1215-22. PubMed ID: 19307171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria.
    Buijs J; Dofferhoff AS; Mouton JW; Wagenvoort JH; van der Meer JW
    Clin Microbiol Infect; 2008 Apr; 14(4):344-9. PubMed ID: 18261128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low endotoxin release from Escherichia coli and Bacteroides fragilis during exposure to moxifloxacin.
    Trautmann M; Scheibe C; Wellinghausen N; Holst O; Lepper PM
    Chemotherapy; 2010; 56(5):364-70. PubMed ID: 20926860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of bacterial killing affects the inflammatory response and associated organ dysfunctions in a porcine E. coli intensive care sepsis model.
    Skorup P; Maudsdotter L; Lipcsey M; Larsson A; Sjölin J
    Crit Care; 2020 Nov; 24(1):646. PubMed ID: 33189146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liberation of endotoxin from Escherichia coli by addition of antibiotics.
    Goto H; Nakamura S
    Jpn J Exp Med; 1980 Feb; 50(1):35-43. PubMed ID: 6991738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of Endotoxin, Inflammatory Variables, and Organ Dysfunction After Treatment With Antibiotics in an Escherichia coli Porcine Intensive Care Sepsis Model.
    Skorup P; Maudsdotter L; Tano E; Lipcsey M; Castegren M; Larsson A; Sjölin J
    Crit Care Med; 2018 Jul; 46(7):e634-e641. PubMed ID: 29595561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-antibiotic effect induced by an antibiotic combination: influence of mode, sequence and interval of exposure.
    Li RC; Tang MC
    J Antimicrob Chemother; 2004 Nov; 54(5):904-8. PubMed ID: 15375112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lincomycin-induced endotoxin release in Escherichia coli sepsis: evidence for release in vitro and in vivo.
    Horii T; Kimura T; Nadai M; Kobayashi M
    Int J Infect Dis; 2000; 4(3):118-22. PubMed ID: 11179913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model.
    Skorup P; Maudsdotter L; Lipcsey M; Castegren M; Larsson A; Jonsson AB; Sjölin J
    PLoS One; 2014; 9(2):e90441. PubMed ID: 24587365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments.
    Nielsen EI; Viberg A; Löwdin E; Cars O; Karlsson MO; Sandström M
    Antimicrob Agents Chemother; 2007 Jan; 51(1):128-36. PubMed ID: 17060524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    Clin Microbiol Infect; 2006 Nov; 12(11):1105-11. PubMed ID: 17002610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.